Background: The safety of triple antiemetic therapy consisting of ondansetron, haloperidol, and a steroid, to surgical patients is unknown.
Objective: To determine the incidence of torsade de pointes (TdP) or death following perioperative administration of triple antiemetic therapy.
Methods: A retrospective cohort study identified 19,874 patients who received 22,202 doses of triple antiemetics during the 2.